NEW YORK (GenomeWeb) – Cancer Research UK announced today said it has designated its first three Major Centres and provided them £5 million ($7.9 million) each to support efforts to develop personalized cancer therapies and to detect disease at earlier stages. 

The centers gaining Major Centre status are the Cancer Research UK Oxford Centre, the Cancer Research UK Manchester Centre; and the Cancer Research UK Cambridge Centre. CRUK has a network of 15 research centers in total. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.